Benefit or risk of aspirin treatment of giant cell arteritis: comment on the article by Weyand et al - Reply

被引：0
|
作者：
Weyand, CM [1 ]
Goronzy, JJ [1 ]
机构：
[1] Mayo Clin & Mayo Fdn, Rochester, MN 55905 USA
来源：
ARTHRITIS AND RHEUMATISM | 2002年 / 46卷 / 11期
关键词：
D O I：
10.1002/art.10523
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3113 / 3114
页数：2
相关论文
共 50 条
  • [11] Predictors of visual loss and cerebrovascular accidents in giant cell arteritis:: comment on the article by Gonzalez-Gay et al -: Reply
    Rodríguez-Valverde, V
    Delgado-Rodriguez, M
    Blanco, R
    Martínez-Taboada, VM
    González-Gay, MA
    Figueroa, M
    Uriarte, E
    ARTHRITIS AND RHEUMATISM, 1999, 42 (04): : 826 - 827
  • [12] Disparate results in studies of methotrexate plus corticosteroids in the treatment of giant cell arteritis:: comment on the article by Hoffman et al
    Jover, JA
    Hernández-Garcia, C
    Morado, IC
    Vargas, E
    Bañares, A
    Fernandez-Gutierrez, B
    ARTHRITIS AND RHEUMATISM, 2003, 48 (04): : 1158 - 1159
  • [13] Varicella zoster virus-specific T cell responses in untreated giant cell arteritis: comment on the article by England et al Reply
    England, Bryant R.
    Mikuls, Ted R.
    Curtis, Jeffrey R.
    ARTHRITIS & RHEUMATOLOGY, 2018, 70 (02) : 320 - 320
  • [14] Acute-phase response and the risk of developing ischemic complications in giant cell arteritis: comment on the article by Cid et al
    Schmidt, D
    Vaith, P
    ARTHRITIS AND RHEUMATISM, 2000, 43 (01): : 234 - 235
  • [15] Trends in the inflammatory response in biopsy-proven giant cell arteritis:: comment on the article by Cid et al, and the letters by Nesher and Sonnenblick and Liozon et al -: Reply
    Cid, MC
    Font, C
    Hernández-Rodríguez, J
    de la Sierra, A
    Coll-Vinent, B
    López-Soto, A
    Urbano-Márquez, A
    Grau, JH
    ARTHRITIS AND RHEUMATISM, 2000, 43 (06): : 1428 - 1428
  • [16] Comment on: Statin therapy does not seem to benefit giant cell arteritis - Reply
    Narvaez, Javier
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2008, 38 (01) : 64 - 65
  • [17] Differences between active treatment and placebo groups in the study of induction treatment of giant cell arteritis with high-dose glucocorticoids: comment on the article by Mazlumzadeh et al - Reply
    Goronzy, Jorg J.
    Weyand, Cornelia M.
    Flunder, Gene G.
    Mazlumzadeh, Mehrdad
    ARTHRITIS AND RHEUMATISM, 2007, 56 (05): : 1723 - 1724
  • [18] Functionally Relevant Treg Cells Are Present in Giant Cell Arteritis Lesions: Comment on the Article by Samson et al
    Corbera-Bellalta, Marc
    Planas-Rigol, Ester
    Espigol-Frigole, Georgina
    Lozano, Ester
    Cid, Maria C.
    ARTHRITIS AND RHEUMATISM, 2013, 65 (04): : 1133 - 1134
  • [19] Duration of treatment after eye involvement in giant cell arteritis -: Arashvand, et al reply
    Arashvand, Kayvan
    Alexander, William Leslie
    Dasgupta, Bhaskar
    JOURNAL OF RHEUMATOLOGY, 2008, 35 (06) : 1221 - 1222
  • [20] Reassessing classification criteria for Takayasu arteritis: comment on the article by Lee et al Reply
    Lee, Kwang-Hoon
    Cho, Arthur
    Park, Yong-Beom
    ARTHRITIS AND RHEUMATISM, 2012, 64 (11): : 3819 - 3820
12345